Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 55.80%228.57M | 33.41%183.04M | 17.98%141.12M | -3.93%552.31M | 4.62%148.8M | -2.18%146.7M | -8.16%137.2M | -10.29%119.61M | -23.37%574.92M | -25.14%142.23M |
| Cost of revenue | -2.86%212.29M | -22.21%218.53M | ||||||||
| Gross profit | -4.59%340.03M | -24.06%356.4M | ||||||||
| Operating expense | 47.02%177.38M | 36.58%143.61M | 12.80%112.32M | 6.00%130.26M | 6.96%119.57M | 8.30%120.65M | -2.31%105.15M | 1.17%99.57M | -13.77%122.89M | 142.70%111.79M |
| Staff costs | ---- | ---- | ---- | 5.06%117.44M | ---- | ---- | ---- | ---- | -16.57%111.79M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 15.50%12.82M | ---- | ---- | ---- | ---- | 30.14%11.1M | ---- |
| -Depreciation | ---- | ---- | ---- | 15.50%12.82M | ---- | ---- | ---- | ---- | 30.14%11.1M | ---- |
| Other operating expenses | 45.30%184.49M | 35.77%150.13M | 14.38%120.27M | 5.08%476.28M | 11.89%133.59M | 8.07%126.97M | -2.19%110.58M | 1.77%105.15M | --453.26M | --119.39M |
| Total other operating income | 12.61%7.11M | 20.08%6.52M | 42.56%7.95M | 30.58%31.35M | 84.42%14.03M | 3.99%6.31M | 0.04%5.43M | 13.82%5.58M | --24.01M | --7.61M |
| Operating profit | 96.50%51.19M | 23.03%39.43M | 43.69%28.8M | -10.17%209.77M | -3.97%29.23M | -32.45%26.05M | -23.25%32.05M | -42.58%20.04M | -28.55%233.51M | -82.18%30.44M |
| Net non-operating interest income (expenses) | -64.14%-1.41M | -33.12%-1.26M | 37.14%-611K | 15.33%-3.48M | 33.46%-706K | 19.62%-856K | 8.52%-945K | -2.32%-972K | -94.28%-4.11M | -12.75%-1.06M |
| Non-operating interest expense | 64.14%1.41M | 33.12%1.26M | -37.14%611K | -15.33%3.48M | -33.46%706K | -19.62%856K | -8.52%945K | 2.32%972K | 94.28%4.11M | 12.75%1.06M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -9.43M | 0 | ||||||||
| Income from associates and other participating interests | 1,268.97%678K | -793.33%-268K | -248.65%-774K | -1,528.21%-557K | -461.36%-247K | 90.99%-58K | 90.74%-30K | -121.12%-222K | 102.39%39K | 94.29%-44K |
| Special income (charges) | -90.49%117K | 119.21%1.23M | ||||||||
| Less:Write off | ---- | ---- | ---- | 90.49%-117K | ---- | ---- | ---- | ---- | -119.21%-1.23M | ---- |
| Other non-operating income (expenses) | -4.50%-93.08M | 19.34%-89.07M | ||||||||
| Income before tax | 100.76%50.46M | 21.98%37.91M | 45.44%27.41M | -27.02%103.34M | -3.60%28.28M | -31.79%25.14M | -23.08%31.08M | -46.16%18.85M | -31.34%141.6M | -43.93%29.34M |
| Income tax | 457.38%16.15M | 214.54%10.1M | 91.33%3.51M | -0.68%13.92M | 15.27%5.98M | -23.23%2.9M | 10.61%3.21M | -14.78%1.83M | 137.02%14.02M | 45.27%5.19M |
| Net income | 54.28%34.31M | -0.21%27.81M | 40.50%23.91M | -29.91%89.42M | -7.66%22.3M | -32.77%22.24M | -25.69%27.87M | -48.21%17.02M | -36.31%127.59M | -50.46%24.15M |
| Net income continuous operations | 54.28%34.31M | -0.21%27.81M | 40.50%23.91M | -29.91%89.42M | -7.66%22.3M | -32.77%22.24M | -25.69%27.87M | -48.21%17.02M | -36.31%127.59M | -50.46%24.15M |
| Noncontrolling interests | -91.04%-405K | -38.72%-326K | -18.14%-254K | -30.91%-936K | -10.04%-274K | -21.84%-212K | -52.60%-235K | -55.80%-215K | -44.15%-715K | -266.00%-249K |
| Net income attributable to the company | 54.63%34.72M | 0.11%28.13M | 40.22%24.16M | -29.57%90.36M | -7.48%22.58M | -32.48%22.45M | -25.37%28.1M | -47.78%17.23M | -36.11%128.3M | -49.79%24.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 54.63%34.72M | 0.11%28.13M | 40.22%24.16M | -29.57%90.36M | -7.48%22.58M | -32.48%22.45M | -25.37%28.1M | -47.78%17.23M | -36.11%128.3M | -49.79%24.4M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 53.78%0.0183 | 0.00%0.0149 | 40.66%0.0128 | -29.60%0.0478 | -7.75%0.0119 | -32.39%0.0119 | -25.13%0.0149 | -47.85%0.0091 | -36.12%0.0679 | -49.90%0.0129 |
| Diluted earnings per share | 55.08%0.0183 | 0.00%0.0148 | 39.56%0.0127 | -29.38%0.0476 | -7.03%0.0119 | -32.57%0.0118 | -24.87%0.0148 | -42.77%0.0091 | -30.41%0.0674 | -45.30%0.0128 |
| Dividend per share | 0 | -36.36%0.007 | 0 | -40.74%0.016 | -20.00%0.005 | 0 | -46.99%0.011 | 0 | 17.90%0.027 | 0.00%0.0063 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.